Seeking Alpha

More on Monsanto's (MON) FQ4 results: In addition to missing its EPS and revenue numbers, MON...

More on Monsanto's (MON) FQ4 results: In addition to missing its EPS and revenue numbers, MON issues downside guidance for FY 2013, seeing EPS of $4.18-$4.32 vs. $4.37 analyst consensus. For FY 2012, Seeds and Genomics sales were $9.8B, a 14% increase Y/Y; FQ4 sales in the segment were $1.2B, 10% lower Y/Y. MON -3.1% premarket.
Comments (1)
  • “The biotech industry is taking us into a more pesticide-dependent agriculture when they’ve always promised, and we need to be going in, the opposite direction,” said Bill Freese, a science policy analyst for the Center for Food Safety in Washington.
    3 Oct 2012, 10:04 AM Reply Like
DJIA (DIA) S&P 500 (SPY)